Portland, Oregon
Phase 1 cancer trials in Portland, OR
55 Phase 1 cancer studies are recruiting participants at sites in Portland as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Portland at a glance
- 55 studies are recruiting at a site in Portland.
- By phase: Early Phase 1 (2), Phase 1 (22), Phase 1/2 (31).
- By sponsor: industry (45), university, hospital or other (10).
- By research area: Lung Cancer (18), Lymphoma (14), Breast Cancer (13), Prostate Cancer (6), Pancreatic Cancer (4).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Portland
Basic details from each study's public record (the 30 most recently updated of 55). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- Providence Cancer Institute
- Registry record
- NCT06253871 · updated
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Study site
- Providence Cancer Institute Franz Clinic
- Registry record
- NCT06638307 · updated
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- Compass Oncology - Rose Quarter
- Registry record
- NCT05579366 · updated
A Study of MGC026 in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- MacroGenics
- Study site
- Providence Cancer Institute
- Registry record
- NCT06242470 · updated
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study sites
- Providence Cancer Institute (Westside) · Providence Portland Medical Center
- Registry record
- NCT06293898 · updated
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- PMV Pharmaceuticals, Inc
- Study site
- Oregon Health & Science University (OHSU)
- Registry record
- NCT04585750 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Portland, OR on ClinicalTrials.gov.
Lung cancer studies recruiting in Portland
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Novelty Nobility, Inc.
- Study site
- Oregon Health & Science University
- Registry record
- NCT06805825 · updated
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- Providence Cancer Institute
- Registry record
- NCT07080242 · updated
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107)
- Registry record
- NCT07227597 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- OHSU Knight Cancer Institute
- Registry record
- NCT07397338 · updated
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Providence Cancer Institute
- Registry record
- NCT07542704 · updated
SW-682 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
- Study site
- Oregon Health and Science University, Knight Cancer Institute - Marquam Hill
- Registry record
- NCT06251310 · updated
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Synthekine
- Study site
- Providence Cancer Institute
- Registry record
- NCT05098132 · updated
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Providence Portland Medical Center ( Site 1101)
- Registry record
- NCT06780137 · updated
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Phase 1/2
- Ages 18 to 130
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT05797168 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #51
- Registry record
- NCT05176483 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Portland, OR on ClinicalTrials.gov.
Prostate cancer studies recruiting in Portland
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Regeneron Pharmaceuticals
- Study site
- Oregon Health & Science University (3485 S. Bond)
- Registry record
- NCT03972657 · updated
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Oregon Health And Science University
- Registry record
- NCT06095089 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- Oregon Health and Science University
- Registry record
- NCT05919264 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Portland, OR on ClinicalTrials.gov.
Lymphoma studies recruiting in Portland
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study sites
- Legacy Emanuel Children's Hospital · Oregon Health and Science University
- Registry record
- NCT04726241 · updated
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Phase 1/2
- Up to age 1
- All sexes
- Sponsor
- Tanja Andrea Gruber
- Study site
- Doernbecher Children's Hospital
- Registry record
- NCT05848687 · updated
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Phase 1/2
- From 6 months, up to 25 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Oregon Health and Science University ( Site 1004)
- Registry record
- NCT06395103 · updated
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT06564038 · updated
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Phase 1/2
- Ages 13 to 90
- All sexes
- Sponsor
- Vironexis Biotherapeutics Inc.
- Study site
- Oregon Health & Science University
- Registry record
- NCT06533579 · updated
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Phase 1/2
- From 30 days
- All sexes
- Sponsor
- Syndax Pharmaceuticals
- Study site
- Oregon Health & Science University
- Registry record
- NCT04065399 · updated
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Curis, Inc.
- Study site
- Providence Neurological Specialties West
- Registry record
- NCT03328078 · updated
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Estrella Immunopharma, Inc.
- Study site
- Oregon Health and Sciences University
- Registry record
- NCT06343311 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Portland, OR on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Portland
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- RayzeBio, Inc.
- Registry record
- NCT07165132 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study site
- Oregon Health & Science University
- Registry record
- NCT04657068 · updated
OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
- Early Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- OHSU Knight Cancer Institute
- Study site
- OHSU Knight Cancer Institute
- Registry record
- NCT07089940 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Portland, OR on ClinicalTrials.gov.
Ask about studies near Portland
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections